Pancoast tumor other diagnostic studies: Difference between revisions
Created page with "__NOTOC__ {{Pancoast tumor}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. ==References== {{..." |
No edit summary |
||
(15 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pancoast tumor}} | {{Pancoast tumor}} | ||
{{CMG}}; {{AE}} {{Mazia}} | |||
==Overveiw== | |||
Other [[diagnostic]] studies for evaluating the spread of Pancoast tumor include [[pulmonary angiography]], molecular tests, and [[biopsy]]. | |||
==Other Diagnostic Studies== | |||
Other [[diagnostic]] studies for evaluating the spread of Pancoast tumor include [[pulmonary angiography]], molecular tests, and [[biopsy]]. | |||
===Pulmonary Angiography=== | |||
*On [[pulmonary angiography]], findings of Pancoast tumor may be used for:<ref name="pmid5483666">{{cite journal |vauthors=Delarue NC, Sanders DE, Silverberg SA |title=Complementary value of pulmonary angiography and mediastinoscopy in individualizing treatment for patients with lung cancer |journal=Cancer |volume=26 |issue=6 |pages=1370–8 |year=1970 |pmid=5483666 |doi= |url=}}</ref> | |||
:*Evaluation of central [[pulmonary artery]] [[invasion]] | |||
===Molecular Test=== | |||
Molecular tests include [[epidermal growth factor receptor]] ([[EGFR]]) [[Mutations|mutation]] and [[anaplastic lymphoma kinase]] (ALK) [[mutation]]. Specific targeted agents may be administered to [[patients]] if these [[mutations]] are present. A [[Transthoracic needle aspiration|transthoracic needle biopsy]] and a [[bronchoscopy]] are conducted to [[diagnose]] [[lung cancer]]. | |||
===Biopsy=== | |||
A [[Transthoracic needle aspiration|transthoracic needle biopsy]], guided by [[CT-scans|CT]] or [[fluoroscopy]], is for pancoast tumors located in the [[periphery]] of the [[lungs]] since [[Periphery|peripheral]] [[tumors]] are not accessible through a [[bronchoscope]].<ref name="pmid24484269">{{cite journal |vauthors=Kinsey CM, Arenberg DA |title=Endobronchial ultrasound-guided transbronchial needle aspiration for non-small cell lung cancer staging |journal=Am. J. Respir. Crit. Care Med. |volume=189 |issue=6 |pages=640–9 |year=2014 |pmid=24484269 |doi=10.1164/rccm.201311-2007CI |url=}}<nowiki><ref name="pmid12820712"></nowiki>{{cite journal |vauthors=Yung RC |title=Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy |journal=Respir Care Clin N Am |volume=9 |issue=1 |pages=51–76 |year=2003 |pmid=12820712 |doi= |url=}}</ref><ref name="NSCLS2">Squamous cell carcinoma of the lung. Libre Pathology http://librepathology.org/wiki/Squamous_cell_carcinoma_of_the_lung Accessed on March 1, 2016</ref> | |||
*Other [[diagnostic]] modalities for pancoast tumor include:<ref name="pmid24484269">{{cite journal |vauthors=Kinsey CM, Arenberg DA |title=Endobronchial ultrasound-guided transbronchial needle aspiration for non-small cell lung cancer staging |journal=Am. J. Respir. Crit. Care Med. |volume=189 |issue=6 |pages=640–9 |year=2014 |pmid=24484269 |doi=10.1164/rccm.201311-2007CI |url=}}</ref> | |||
:*[[Thoracotomy]] | |||
:*[[Thoracoscopy]] | |||
:*[[Mediastinoscopy]] | |||
::*[[Chamberlain procedure]] | |||
::*Left parasternal mediastinotomy | |||
::*[[Anterior]] mediastinotomy | |||
:*[[Transthoracic needle aspiration|Transthoracic]] [[percutaneous]] [[fine needle aspiration]] | |||
:*[[Sputum]] [[cytology]] | |||
::*The [[sensitivity]] or [[sputum]] [[cytology]] varies by location of the [[lung cancer]] | |||
*The majority of these procedures allow [[Cancer staging|staging]] of [[mediastinal]] [[lymph nodes]]. | |||
*The table below summarizes the different types of diagnostic modalities for Pancoast tumor arranged from the most to the least [[invasive]].<ref name="staging">Lung Cancer Staging. Wikipedia.https://en.wikipedia.org/wiki/Lung_cancer_staging Accessed on March 1, 2015 </ref> | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align="center" | |||
|+ | |||
|- | |||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Procedure}} | |||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Advantages}} | |||
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Disadvantages}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | [[Thoracotomy]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Allows the most thorough [[Inspection (medicine)|inspection]] and [[sampling]] of [[Lymph nodes|lymph node]] stations | |||
*May be followed by resection of [[tumor]], if feasible | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*[[Invasive]] approach | |||
*Not indicated for [[Staging (pathology)|staging]] alone | |||
*Significant risk of procedure-related [[morbidity]] | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | Left parasternal mediastinotomy | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Allows evaluation of the [[aortopulmonary window]] [[lymph nodes]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*More [[invasive]] | |||
*[[False-negative]] rate approximately 10% | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | [[Chamberlain procedure]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Access to station 5 ([[aortopulmonary window]] lymph node) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Limited applications, [[invasive]] | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | [[Mediastinoscopy|Cervical mediastinoscopy]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Considered the gold standard (usual comparitor) | |||
*Excellent for 2RL 4RL | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*[[Invasive]] | |||
*Does not cover all [[mediastinal]] [[Lymph nodes|lymph node]] stations; particularly subcarinal [[lymph nodes]] (station 7), paraesophageal and [[pulmonary]] ligament [[lymph nodes]] (stations 8 and 9). | |||
*[[False-negative]] rate approximately 20% | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | [[Thoracoscopy|Video-assisted thoracoscopy]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Useful for the evaluation of [[inferior mediastinum]], station 5 and 6 [[lymph nodes]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*[[Invasive]] | |||
*Does not cover superior [[anterior mediastinum]] | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | Transthoracic percutaneous [[fine needle aspiration]] under CT guidance | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Widely available than some other methods | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Traverses a lot of [[lung]] [[tissue]] | |||
*High [[pneumothorax]] risk | |||
*Some [[lymph node]] stations inaccessible | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | [[Bronchoscopy]] with blind transbronchial Wang needle | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Less [[invasive]] than above methods | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Relatively low yield | |||
*Not widely practiced | |||
*[[Bleeding]] risk | |||
|- | |||
|} | |||
==References== | ==References== |
Latest revision as of 18:14, 16 March 2018
Pancoast tumor Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pancoast tumor other diagnostic studies On the Web |
American Roentgen Ray Society Images of Pancoast tumor other diagnostic studies |
Risk calculators and risk factors for Pancoast tumor other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
Overveiw
Other diagnostic studies for evaluating the spread of Pancoast tumor include pulmonary angiography, molecular tests, and biopsy.
Other Diagnostic Studies
Other diagnostic studies for evaluating the spread of Pancoast tumor include pulmonary angiography, molecular tests, and biopsy.
Pulmonary Angiography
- On pulmonary angiography, findings of Pancoast tumor may be used for:[1]
- Evaluation of central pulmonary artery invasion
Molecular Test
Molecular tests include epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) mutation. Specific targeted agents may be administered to patients if these mutations are present. A transthoracic needle biopsy and a bronchoscopy are conducted to diagnose lung cancer.
Biopsy
A transthoracic needle biopsy, guided by CT or fluoroscopy, is for pancoast tumors located in the periphery of the lungs since peripheral tumors are not accessible through a bronchoscope.[2][3]
- Other diagnostic modalities for pancoast tumor include:[2]
-
- Chamberlain procedure
- Left parasternal mediastinotomy
- Anterior mediastinotomy
- The sensitivity or sputum cytology varies by location of the lung cancer
- The majority of these procedures allow staging of mediastinal lymph nodes.
- The table below summarizes the different types of diagnostic modalities for Pancoast tumor arranged from the most to the least invasive.[4]
Procedure | Advantages | Disadvantages |
---|---|---|
Thoracotomy |
|
|
Left parasternal mediastinotomy |
|
|
Chamberlain procedure |
|
|
Cervical mediastinoscopy |
|
|
Video-assisted thoracoscopy |
|
|
Transthoracic percutaneous fine needle aspiration under CT guidance |
|
|
Bronchoscopy with blind transbronchial Wang needle |
|
|
References
- ↑ Delarue NC, Sanders DE, Silverberg SA (1970). "Complementary value of pulmonary angiography and mediastinoscopy in individualizing treatment for patients with lung cancer". Cancer. 26 (6): 1370–8. PMID 5483666.
- ↑ 2.0 2.1 Kinsey CM, Arenberg DA (2014). "Endobronchial ultrasound-guided transbronchial needle aspiration for non-small cell lung cancer staging". Am. J. Respir. Crit. Care Med. 189 (6): 640–9. doi:10.1164/rccm.201311-2007CI. PMID 24484269.<ref name="pmid12820712">Yung RC (2003). "Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy". Respir Care Clin N Am. 9 (1): 51–76. PMID 12820712.
- ↑ Squamous cell carcinoma of the lung. Libre Pathology http://librepathology.org/wiki/Squamous_cell_carcinoma_of_the_lung Accessed on March 1, 2016
- ↑ Lung Cancer Staging. Wikipedia.https://en.wikipedia.org/wiki/Lung_cancer_staging Accessed on March 1, 2015